Saltar al contenido
Merck
Todas las fotos(1)

Documentos clave

805092

Sigma-Aldrich

PLGA nanoparticles

100 nm average diameter

Sinónimos:

Degradex® PLGA, poly(D,L-lactide-co-glycolide)

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Fórmula lineal:
HO(C3H4O2)x(C2H2O2)yH
UNSPSC Code:
12162002
NACRES:
NA.23
En este momento no podemos mostrarle ni los precios ni la disponibilidad

form

powder

Quality Level

100

average diameter

100 nm

density

1.3 g/cm3

shipped in

wet ice

storage temp.

−20°C

Categorías relacionadas

General description

Degradex® is made with poly(D,L-lactide-co-glycolide) with an L/G ratio of 50/50 and a Mw of 30,000.
To re-constitute:
  • Remove the product from freezer.
  • Wait until temperature rises to the ambient temperature.
  • Add DI water or buffer to the container.
  • Vortex and sonicate for 5 minutes to ensure the microspheres are well suspended.
The particle size of the PLGA nanoparticles are closely dependent on both the nature and concentration of the stabilizer and polymer.[1][2]

Application

Plain PLGA particles can be used for testing system compatibility in drug delivery research. Particles can be used as carriers by attaching drug or biological/chemical entities to particle surface. PLGA particles are used for controlled release, sustained release and targeted drug delivery.A study reports the use of PLGA nanoparticles as estrogen carriers. The carrier-drug system was prepared by emulsification-diffusion method.[1][2]

Legal Information

Degradex is a registered trademark of Phosphorex, Inc.

related product

Referencia del producto
Descripción
Precios

911593

NanoFabTx™ microfluidic - nano, device kit for synthesis of 100-200 nm nanoparticles and liposomes

911860

NanoFabTx™ microfluidic - micro, device kit for synthesis of 1-5 μm particles

911879

NanoFabTx™ microfluidic - micro, device kit for synthesis of 10-30 μm particles

909637

NanoFabTx™ PLGA-nano, for synthesis of 100 and 200 nm particles

912212

NanoFabTx™ PLGA-micro, for synthesis of 10-30 um particles

912220

NanoFabTx™ PLGA-micro, for synthesis of 1-5 μm particles

920436

NanoFabTx™ PEG-PLA drug formulation screening kit, for synthesis of PEGylated nanoparticles

915408

NanoFabTx™ PEGylated nanoparticle formulation screening kit

917796

NanoFabTx™ PEG-PLGA drug formulation screening kit, for synthesis of PEGylated nanoparticles

918881

NanoFabTx™ PEG-PCL drug formulation screening kit, for synthesis of PEGylated nanoparticles

918075

NanoFabTx™ PLA-nano, for synthesis of 100 and 200 nm particles

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number
MKCX0810
MKCW1688
MKCT2852
MKCT9440
MKCR7346

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

Busque por un COA

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

The Characteristics and Mechanisms of Uptake of PLGA Nanoparticles in Rabbit Conjunctival Epithelial Cell Layers
Qaddoumi MG, et al.
Pharmaceut. Res., 21(4), 641-648 null
Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method
Kwon HY, et al.
Colloids and Surfaces. A, Physicochemical and Engineering Aspects, 182(1-3), 123-130 (2001)

Artículos

Degradex® Microspheres and Nanoparticles for Drug Delivery Research and Formulation Development

Study on how Degradex® PLGA microspheres and nanoparticles can be used for drug delivery research and formulation development.

Degradex® Microspheres and Nanoparticles for Drug Delivery Research and Formulation Development

Study on how Degradex® PLGA microspheres and nanoparticles can be used for drug delivery research and formulation development.

Degradex® Microspheres and Nanoparticles for Drug Delivery Research and Formulation Development

Study on how Degradex® PLGA microspheres and nanoparticles can be used for drug delivery research and formulation development.

Degradex® Microspheres and Nanoparticles for Drug Delivery Research and Formulation Development

Study on how Degradex® PLGA microspheres and nanoparticles can be used for drug delivery research and formulation development.

Ver todo

Questions

  1. Need more info on how to use the particles: How long are the PLGA nanoparticles stable for once reconstituted in water/PBS? Is 20mg/ml a good concentration to resuspend at? Presumably they should be stored at 4°C instead of refrozen once reconstituted?

    1 answer

    1. The stability of the PLGA nanoparticles in the solution is not determined. However, various sources state that suspensions may be stable for greater than 2 weeks in aqueous buffers when stored at 4°C. See the link below for preparation and surface conjugation instructions. Allow the product to reach room temperature before suspending it in water or buffer. Suspensions may require vertexing or sonication:
      https://www.sigmaaldrich.com/technical-documents/technical-article/materials-science-and-engineering/drug-delivery/egradex-microspheres-nanoparticles

      It may be helpful to review the additional publications below:
      https://pubs.acs.org/doi/pdf/10.1021/acs.macromol.0c00110

      Helpful?

Reviews

No rating value

Active Filters

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico